|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schiller JH: A new standard of care for
advanced lung cancer. N Engl J Med. 378:2135–2137. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pugh DJ, Ab E, Faro A, Lutya PT, Hoffmann
E and Rees DJ: DWNN, a novel ubiquitin-like domain, implicates
RBBP6 in mRNA processing and ubiquitin-like pathways. BMC Struct
Biol. 6:12006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoshitake Y, Nakatsura T, Monji M, Senju
S, Matsuyoshi H, Tsukamoto H, Hosaka S, Komori H, Fukuma D, Ikuta
Y, et al: Proliferation potential-related protein, an ideal
esophageal cancer antigen for immunotherapy, identified using
complementary DNA microarray analysis. Clin Cancer Res.
10:6437–6448. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Motadi LR, Bhoola KD and Dlamini Z:
Expression and function of retinoblastoma binding protein 6 (RBBP6)
in human lung cancer. Immunobiology. 216:1065–1073. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mbita Z, Meyer M, Skepu A, Hosie M, Rees J
and Dlamini Z: De-regulation of the RBBP6 isoform 3/DWNN in human
cancers. Mol Cell Biochem. 362:249–262. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chibi M, Meyer M, Skepu A, G Rees DJ,
Moolman-Smook JC and Pugh DJ: RBBP6 interacts with multifunctional
protein YB-1 through its RING finger domain, leading to
ubiquitination and proteosomal degradation of YB-1. J Mol Biol.
384:908–916. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen J, Tang H, Wu Z, Zhou C, Jiang T, Xue
Y, Huang G, Yan D and Peng Z: Overexpression of RBBP6, alone or
combined with mutant TP53, is predictive of poor prognosis in colon
cancer. PLoS One. 8:e665242013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Travis WD, Bramblilla E, Müller-Hermelink
HK and Harris CC: Tumours of the Lung, Pleura, Thymus and Heart.
Pathology and Genetics. World Health Organization (WHO); IARC
Press, Lyon: 2004
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao Z, Fenoglio S, Gao DC, Camiolo M,
Stiles B, Lindsted T, Schlederer M, Johns C, Altorki N, Mittal V,
et al: TGF-beta IL-6 axis mediates selective and adaptive
mechanisms of resistance to molecular targeted therapy in lung
cancer. Proc Natl Acad Sci USA. 107:15535–15540. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L, Luo Q, Xie Z, Li G, Mao C, Liu Y,
Wen X, Yin N, Cao J, Wang J, et al: Characterization of the
expression of the RNA binding protein eIF4G1 and its
clinicopathological correlation with serous ovarian cancer. PLoS
One. 11:e01634472016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Simons A, Melamed-Bessudo C, Wolkowicz R,
Sperling J, Sperling R, Eisenbach L and Rotter V: PACT: Cloning and
characterization of a cellular p53 binding protein that interacts
with Rb. Oncogene. 14:145–155. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Witte MM and Scott RE: The proliferation
potential protein-related (P2P-R) gene with domains encoding
heterogeneous nuclear ribonucleoprotein association and Rb1 binding
shows repressed expression during terminal differentiation. Proc
Natl Acad Sci USA. 94:1212–1217. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sakai Y, Saijo M, Coelho K, Kishino T,
Niikawa N and Taya Y: cDNA sequence and chromosomal localization of
a novel human protein, RBQ-1 (RBBP6), that binds to the
retinoblastoma gene product. Genomics. 30:98–101. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moela P, Choene MM and Motadi LR:
Silencing RBBP6 (Retinoblastoma Binding Protein 6) sensitises
breast cancer cells MCF7 to staurosporine and camptothecin-induced
cell death. Immunobiology. 219:593–601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moela P and Motadi LR: RBBP6: A potential
biomarker of apoptosis induction in human cervical cancer cell
lines. Onco Targets Ther. 9:4721–4735. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scott RE, Giannakouros T, Gao S and Peidis
P: Functional potential of P2P-R: A role in the cell cycle and cell
differentiation related to its interactions with proteins that bind
to matrix associated regions of DNA? J Cell Biochem. 90:6–12. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dlamini Z, Rupnarain C, Naicker S, Hull R
and Mbita Z: Expression analysis and association of RBBP6 with
apoptosis in colon cancers. J Mol Histol. 47:169–182. 2016.
View Article : Google Scholar : PubMed/NCBI
|
